brentuximab vedotin
seagen
['hodgkin', 'seagen']
data results from the german hodgkin study group s international phase 3 trial that included our medicine for advanced #hl will be shared in a late-breaking presentation june 17. learn about the study from #17icml:
Official Twitter for Seagen. Global biotechnology company focused on transformative cancer medicines to improve lives. Guidelines https://t.co/mK6wXiXw22